Isolation, characterization, and genome analysis of novel bacteriophage - Stenotrophomonas phageCM1

Calmly M Koshy1, Shobana Sugumar1

  • 1Department of Genetic Engineering, Faculty of Engineering and Technology, School of Bioengineering, SRM Institute of Science and Technology, SRM Nagar, Kattankulathur, Kanchipuram, Chennai, Tamil Nadu, 603203, India.

Microbial Pathogenesis
|October 25, 2023
PubMed

Insights

Researchers isolated and characterized Stenotrophomonas phage CM1, a promising bacteriophage therapy candidate effective against the antibiotic-resistant bacterium Stenotrophomonas maltophilia, offering new hope for treating nosocomial infections.

Area of Science:

  • Microbiology and Virology
  • Bacteriophage Therapy
  • Antimicrobial Resistance

Background:

  • Stenotrophomonas maltophilia is a significant cause of nosocomial infections, particularly in immunocompromised patients.
  • The increasing antibiotic resistance of S. maltophilia poses a major clinical challenge.
  • Bacteriophage therapy presents a promising alternative treatment strategy.

Purpose of the Study:

  • To isolate, identify, and characterize a novel bacteriophage, designated CM1, targeting Stenotrophomonas maltophilia.
  • To evaluate the physical, biochemical, and genomic properties of Stenotrophomonas phage CM1.

Main Methods:

  • Isolation and identification of Stenotrophomonas phage CM1 from environmental samples.
  • Morphological characterization using electron microscopy (head diameter, tail length, tail spikes).
  • Determination of optimal growth conditions (pH, temperature stability, chloroform sensitivity).
  • Genomic analysis including size, GC content, open-reading frame (ORF) identification, and phylogenetic analysis.

Main Results:

  • Stenotrophomonas phage CM1, belonging to the Myoviridae family, exhibits a head diameter of ~224 nm and a tail length of ~159 nm with distinct tail spikes.
  • The phage demonstrates optimal activity at pH 7, good thermal stability (37-60°C), and marginal infectivity loss in 1-5% chloroform.
  • The phage genome is 319,518 bp with 43.9% GC content, containing 559 ORFs, including hypothetical proteins, known proteins, tRNAs, and a restriction enzyme. Phylogenetic analysis indicates a close relationship with other Stenotrophomonas phages.

Conclusions:

  • Stenotrophomonas phage CM1 is a well-characterized bacteriophage with potential for therapeutic applications against S. maltophilia.
  • Its distinct morphological and genomic features, along with its stability, support its candidacy for further development in phage therapy.
  • The study contributes to the growing body of research on bacteriophages as a viable strategy to combat multidrug-resistant bacteria.

Related Concept Videos

DNA Bacteriophages01:26

DNA Bacteriophages

Bacteriophages, or phages, are viruses that specifically infect bacteria, utilizing their genetic material to hijack host cellular machinery for replication. DNA bacteriophages employ single-stranded DNA (ssDNA) or double-stranded DNA (dsDNA) genomes. These phages exhibit diverse replication strategies and host interactions, influencing their ecological roles and applications in biotechnology and medicine.ssDNA BacteriophagesssDNA phages, with their small genomes, utilize unique strategies to...
27
Modern Molecular Taxonomy01:29

Modern Molecular Taxonomy

Advancements in molecular biology have revolutionized the identification and characterization of bacteria, with multiple methods leveraging DNA sequencing for enhanced precision. As sequencing technologies improve and costs decline, these approaches are increasingly used in clinical, environmental, and evolutionary studies.Multilocus Sequence Typing (MLST) examines several housekeeping genes, essential chromosomal genes encoding cellular functions, to distinguish strains. Approximately...
26
Lytic Cycle of Bacteriophages01:30

Lytic Cycle of Bacteriophages

Bacteriophages, also known as phages, are specialized viruses that infect bacteria. A key characteristic of phages is their distinctive “head-tail” morphology. A phage begins the infection process (i.e., lytic cycle) by attaching to the outside of a bacterial cell. Attachment is accomplished via proteins in the phage tail that bind to specific receptor proteins on the outer surface of the bacterium. The tail injects the phage’s DNA genome into the bacterial cytoplasm. In the...
70.8K
Viral Replication: Lytic Cycle01:20

Viral Replication: Lytic Cycle

Bacteriophages, or phages, are viruses that specifically infect bacteria. Among them, T-even bacteriophages, such as T4, exhibit a well-characterized lytic replication cycle in Escherichia coli (E. coli). This process ensures the rapid proliferation of the virus while ultimately leading to the destruction of the bacterial host.Attachment and DNA InjectionThe infection process begins with the recognition and binding of the T4 phage to the E. coli cell surface. Tail fibers of the phage...
32